Member Info for martinu

Seems he is a local govt official.

Link to photo of Jaron, supervisor at NF on Facebook. From Strangl linked in account. Little write up too.

https://m.facebook.com/story.php?story_fbid=pfbid0hwvyKqLijB9WdwphxSLQ7WQiWNoeSuziDAgqtoFhN5CsYcdSwNyw1rrVkGjA5ySal&id=100063759698308

Mol, there is a bit of the "I've heard this before" in the presentation. But, and here SOH has perhaps 2 years to regain credibility , there are new partners in USA who are hopefully coming on board this year. (SOH more bullish on this of course). Along with a recognition by SOH that we relied on too few partners. Also, destocking and product launch/marketing suspension is expected to stop with no new shocks to World politics.

Reiterated plan for PBX. Move to more liquid exchange, fatten up and trade sale. Steen's forte. Not exactly an apology but some acknowledgement re Aquis.

On Sweet, said the Dec sample was liquid which needs to be powder /crystal. Commercialisation 23/24. So still a wait and need for faith. Said Firminech had caught up the US partner in terms of development. Also, F came on board due to impressive patents.

This is my interpretation from memory and a few notes. I'm not giving up yet. I'm giving him 2 years. So eg FY 24 figures. I'm 68 1/2, so I hope I am around to collect!?

RoR, excellent. Hope the word gets spread widely. Rather than the Eqtec super-detectives having to unearth.

OK, it's difficult to judge this presentation with an open mind because of the disastrous 2022. Also due to endless process of getting SweetBiotix to commercialisation. And partners failing to deliver.

BUT ... I think SOH has at least tried to present the outlook in a different way, to make most of the presentation worth a 2nd look. I've just watched for the 1st time. Of course his credibility has taken a hit, so he can't afford to be far off with his current "non-forecasts". But there is enough in the presentation for me to give him another 18 months to turn this around! (I'll have to watch again to pick out the detail).

Call me gullible... Sweet(Bio) dreams all :))

Mol, thanks for posting. A bit confusing that it is under the Opti banner and not PBX. If it is new news, will depend on revenues as to whether it is good news. Sounds promising on the face of it.

Mja, fair points. For me, it's not the delay but the lack of communication. I was under the impression that the Italy handover should have already happened. If there is a problem they should say so. Biochar qualify was due to be tested in Switzerland in April. Nothing on that.

As this project is so important as a showcase, I feel shareholders should be kept up to date. They have plenty of SM platforms if any news is not market sensitive.

Agree, completely embarrassing.

Surely we won't get financials after the presentation!

Auf Englisch, Deutsch oder Italienisch?

VH so are you saying you have been to the Italy MDC plant and had a look around?

Don't think BOD have ever lacked for confidence. Esp VDL. Possibly over confident at times. Italy MDC should be the turning point, but we are already hanging on for "handover" and biochar analysis. Time to start delivering in more timely fashion.

I, too, have noticed PBX almost operating together with Opti. In some ways it may make economic sense. But why split?

Was bedeutet "lauzig"?

When I said here is the link, I meant...
https://eqtec.com/investing-in-eqtec/financial-reports/

For anyone wanting the full report, below is a link to where you can download the pdf. DPs report is crucial to me, as he will be judged on (improved or not) timely delivery of the outlooks for 2023.

PS: Croqman, couldn't agree more.

There is a lot to read through and digest in the full report. First impressions:
Negative: N Fork
Positive: France

And whilst costs have been reined in, there still seems a desire to accelerate before stabilisation is assured. I am still trying to get my head around likely revenue streams (and value of these) for 2023. Italy, Croatia, Greece, France. All still with question marks over actual timescale (for now).

The report did say company forecasts have been made up to Apr 24. Though f/c were well wide of the mark before, due to UK project. I guess there may be an update from in house analysts.

I imagine most Eqt shareholders will be expecting very poor numbers on Friday. IMO Eqt have a period of about 18 months to build on Italia MDC, by getting other small scale projects up and running and showing timely progress with other projects and most importantly, bringing in regular revenues. And of course, moving towards profitability.

We shall see.

Trat Thanks for posting. So WW says NF is still looking for funding. Our Feb RNS says,

"On 12 October 2022, the Company announced that, following many months of delay due to a combination of local forest fires, pandemic-related challenges in labour and supply chain and the ensuing need to re-finance the project to address delays, NFCP had entered into an agreement for financial restructuring with the project lenders towards full funding of the project up to the commercial operations date ("COD") of the North Fork, California plant. It further revealed that the third-party funding had been agreed through pre-negotiated, Chapter 11 bankruptcy arrangements. The restructure project finance has enabled work to restart at the site and the Company anticipates that NFCP will reach COD later in 2023. Three of the Company's executive directors will be on site there in February, toward development of the plan for both technical and business readiness of the plant."

So is NF funded or not? Sorry if it's obvious.

Thanks for posting. Very interesting and hopefully (all fingers crossed), Opti will benefit from this trend, eventually.